Source

Lancet Diabetes & Endocrinology .

Takeaway

In adults with basal insulin-treated type 2 diabetes (T2D), once-weekly icodec showed statistical superiority in haemoglobin A1c (HbA1c) after 26 weeks, associated with modest weight gain, compared with once-daily degludec.

Overall hypoglycaemia rates were low, with numerically but not statistically significantly higher rates...